Treatment of non-alcoholic fatty liver disease by Qianggan Capsule (强肝胶囊)
Authors:
- 4 February 2010
- journal article
- research article
- Published by Springer Nature in Chinese Journal of Integrative Medicine
- Vol. 16 (1) , 23-27
Abstract
To observe the therapeutic effect and safety of Qianggan Capsule (强肝胶囊, QGC) in treating non-alcoholic fatty liver disease (NAFLD), using polyene phosphatidylcholine capsule (PPC) as a reference.Keywords
This publication has 3 references indexed in Scilit:
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazoneHepatology, 2003
- Non‐alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics, 2003
- [Stress on research of nonalcoholic fatty liver disease].2003